Vitamin K Shots and Newborn Bleeding: What Evidence Shows

Newborns naturally have low vitamin K levels. Without enough vitamin K, blood cannot clot normally, creating a risk of vitamin K deficiency bleeding (VKDB). Bleeding may affect the skin, digestive tract, or brain and can develop without obvious warning.

The vitamin K injection given after birth helps prevent this complication. It is not a vaccine. It is a preventive medication that supplies the vitamin needed to activate several clotting proteins.

Hospital reports and public health investigations have linked refusal of the injection with severe infant bleeding. However, the phrase “bleeding surged” requires careful interpretation. The size of any increase depends on the population studied, the comparison period, the use of oral vitamin K, and the number of infants who declined prophylaxis.

The practical conclusion is clear: newborns who do not receive intramuscular vitamin K have a higher risk of VKDB, and late bleeding can be sudden, internal, and life-threatening.

What Is Vitamin K Deficiency Bleeding?

Vitamin K deficiency bleeding occurs when an infant does not have enough vitamin K to produce functional clotting proteins. It was formerly called hemorrhagic disease of the newborn.

Bleeding may occur in visible locations, such as the umbilical stump or gastrointestinal tract. It can also occur internally, including inside the skull. Intracranial bleeding may cause seizures, brain injury, developmental disability, or death.

VKDB is classified by when it develops:

• Early VKDB: During the first 24 hours after birth.
• Classical VKDB: Usually during the first week of life.
• Late VKDB: From approximately the second week through the first several months.

The Centers for Disease Control and Prevention states that late VKDB can occur in infants up to six months old and may involve bleeding in the brain or intestines Source 1.

Early VKDB

Early VKDB occurs within the first day of life. It is uncommon but may be associated with maternal use of medicines that interfere with vitamin K metabolism, including some anticonvulsants, antibiotics, and anticoagulants.

This form can be severe. A newborn may require urgent testing, vitamin K treatment, blood products, and evaluation for an underlying condition.

Classical VKDB

Classical VKDB generally occurs during the first week. Possible bleeding sites include:

• The umbilical stump.
• The skin.
• The gastrointestinal tract.
• The nose or mouth.
• A circumcision site.
• Areas affected by minor injury.

Bruising, pallor, persistent bleeding, or blood in vomit or stool requires medical assessment. Not every case begins with dramatic bleeding.

Late VKDB

Late VKDB develops after the first week and may occur during the first months of infancy. It can affect babies who appeared healthy at birth.

Brain bleeding is a major concern. A baby may initially show nonspecific symptoms, such as poor feeding, repeated vomiting, unusual sleepiness, irritability, weakness, or reduced movement. Seizures or difficulty waking indicate an emergency.

Late VKDB is more common among exclusively breastfed infants who did not receive vitamin K prophylaxis because breast milk contains less vitamin K than standard infant formula. This does not mean breastfeeding is unsafe or should be avoided. It means breastfeeding does not reliably provide the protection supplied by the injection.

Why Newborns Have Low Vitamin K

Newborns are vulnerable for several biological reasons.

Limited Transfer Before Birth

Only small amounts of vitamin K cross the placenta. Babies therefore begin life with low stores compared with older children and adults.

Immature Intestinal Bacteria

Older children and adults obtain vitamin K partly through intestinal bacteria. Newborns have not yet developed a stable bacterial population capable of producing reliable amounts.

Low Vitamin K in Human Milk

Human milk provides important nutrition and immune benefits, but it contains relatively little vitamin K. Formula-fed infants receive more vitamin K through feeding, although feeding alone is not considered a substitute for recommended newborn prophylaxis.

Certain medical conditions can increase risk further. These include liver disease, problems absorbing fats, prolonged antibiotic exposure, and undiagnosed disorders affecting blood clotting.

What the Vitamin K Shot Does

The vitamin K injection supplies a concentrated dose that enables the liver to activate clotting proteins. It reduces the risk of early, classical, and late VKDB.

The injection is preventive treatment, not a vaccine. Vaccines train the immune system to recognize infectious threats. Vitamin K supports the chemical process required for normal blood clotting.

The American Academy of Pediatrics has recommended routine vitamin K administration for newborns since 1961. Its policy statement concludes that a single intramuscular dose after birth is the most effective prevention for VKDB Source 2.

Timing After Birth

Hospitals commonly administer vitamin K shortly after delivery, according to local clinical policy. Parents can ask:

• When will the injection be given?
• What dose and formulation will be used?
• How will it be documented?
• What happens if the baby is unstable or cannot receive it immediately?
• How is administration recorded in the discharge paperwork?

The maternity team can explain the exact protocol used at that facility.

Expected Side Effects

Common effects include:

• Brief pain from the injection.
• Short-term fussiness.
• Minor redness, swelling, or tenderness at the injection site.

Serious reactions are uncommon. Parents should discuss specific concerns with the newborn’s clinician, particularly when the baby has a medical condition or cannot receive an injection immediately.

What Studies Have Found About Refusing Vitamin K

Researchers have examined VKDB reports, hospital records, public health surveillance, and comparisons between infants who received prophylaxis and those who did not.

One important example came from Tennessee. The Centers for Disease Control and Prevention described four infants with late VKDB in 2013 and 2014. All four had not received intramuscular vitamin K at birth. Three had intracranial bleeding, and one had gastrointestinal bleeding. The cases were reported in a public health investigation after healthcare providers noticed a cluster Source 3.

The report did not prove that refusal was the only factor in every case. It did show a consistent and clinically important pattern: infants who did not receive the injection developed serious bleeding weeks after birth, despite appearing healthy earlier.

Earlier research found a similar association. A national surveillance study in the Netherlands examined late VKDB and reported a substantially higher incidence among infants who did not receive the recommended vitamin K regimen than among those who did. The study also identified intracranial bleeding as a serious outcome Source 4.

Risk estimates vary because countries use different doses, oral schedules, surveillance systems, and definitions of VKDB. A study of refusal in one hospital or region cannot automatically describe every newborn population.

Why Refusal Studies Require Careful Interpretation

Infants whose parents decline the injection may differ from infants who receive it in several ways. They may be:

• More likely to be exclusively breastfed.
• Less likely to complete an oral regimen.
• Less likely to receive timely follow-up.
• Born in settings with different clinical practices.
• Affected by medical conditions not recognized immediately.

These factors can influence the observed rate of bleeding. Researchers therefore need to report the population size, definition of refusal, prophylaxis offered, follow-up procedures, and number and severity of bleeding cases.

Possible confounding does not eliminate the central finding. The injection is the most reliable prevention available in routine newborn care, and declining it removes that protection.

Why Bleeding Risk Increases Without the Injection

The Standard Protection Is Removed

Without intramuscular vitamin K, the newborn remains dependent on naturally low stores, developing intestinal bacteria, and dietary intake. These sources may not provide enough vitamin K during the vulnerable first months.

Oral Vitamin K May Not Be Equivalent

Some healthcare systems offer oral vitamin K when parents decline an injection. Oral regimens typically require multiple doses. Protection may depend on:

• Receiving every scheduled dose.
• Absorbing each dose.
• Avoiding vomiting after administration.
• Following the specific product instructions.
• Completing follow-up with a clinician.

The exact regimen differs by country and product. Oral vitamin K is not automatically equivalent to intramuscular prophylaxis, and some oral schedules provide less reliable protection against late VKDB. The Canadian Paediatric Society recommends intramuscular vitamin K and describes oral administration as a less effective alternative when parents decline injection Source 5.

Parents should not substitute an over-the-counter product without medical guidance. Product concentration, formulation, dosing, and regulatory approval vary.

Internal Bleeding Can Be Missed

VKDB may begin inside the body. A parent may not see blood until the infant is seriously ill. A baby with intracranial bleeding may first appear unusually sleepy, feed poorly, vomit, develop seizures, or behave differently.

Waiting for visible blood can delay treatment.

Symptoms That Require Immediate Medical Attention

Seek urgent medical care for:

• Blood in vomit.
• Red blood in stool or black, tarry stool.
• Bleeding from the umbilical stump that does not stop.
• Persistent nose or mouth bleeding.
• Unusual bruising or widespread pinpoint skin spots.
• Pale or gray skin.
• Weakness, limpness, or extreme sleepiness.
• Repeated vomiting.
• Poor feeding or a sudden change in feeding.
• Seizures.
• Difficulty waking the baby.
• A tense or bulging soft spot.
• Sudden changes in movement, behavior, or responsiveness.

Call emergency services for seizures, difficulty breathing, collapse, severe lethargy, suspected shock, or signs of brain bleeding. Do not wait for a routine pediatric appointment.

These symptoms can result from conditions other than VKDB, but all require prompt assessment.

Questions Parents Should Ask Before Delivery

Parents can discuss vitamin K during prenatal visits rather than waiting until labor.

Questions About Hospital Policy

Ask:

1. When is vitamin K administered?
2. Which formulation and dose are used?
3. Who gives the injection?
4. How is administration recorded?
5. What happens if the baby is premature, ill, or unable to receive it immediately?

Questions About Alternatives

If considering oral vitamin K, ask:

1. Is an oral regimen available locally?
2. How many doses are required?
3. What are the exact dosing dates?
4. What should parents do if the baby vomits?
5. What happens after a missed dose?
6. How effective is the regimen compared with injection?
7. Is it appropriate for a premature or medically complex infant?

Questions About Individual Risk

Tell the clinician about:

• Maternal medications.
• Liver disease.
• Malabsorption conditions.
• Family history of bleeding disorders.
• Prematurity.
• Exclusive breastfeeding plans.
• Neonatal illness.
• Previous children with unexplained bleeding.

If parents decline the injection, they should request a written follow-up plan and clear emergency instructions.

How Clinicians Can Discuss Vitamin K

A productive conversation starts with the parent’s concerns. Some parents worry about injection pain, ingredients, dosage, long-term effects, or confusion between vitamin K and vaccines.

Clinicians can explain that:

• The injection is a medication, not a vaccine.
• Newborns have biologically low vitamin K levels.
• VKDB can occur in babies who looked healthy at birth.
• Brain bleeding may occur without early visible warning.
• The injection provides more reliable protection than most oral schedules.
• The expected benefit is prevention of a rare but potentially catastrophic event.

Shared decision-making requires clear information about benefits, side effects, uncertainties, and alternatives. Parents should receive written warning signs if prophylaxis is declined.

What the Evidence Does Not Prove

Studies linking refusal with VKDB do not prove that every bleeding case was caused solely by refusal. Prematurity, liver disease, malabsorption, breastfeeding, delayed diagnosis, and other factors can contribute.

The word “surge” should be used only when a report provides:

• A defined comparison period.
• A verified baseline rate.
• A clearly described population.
• The number of cases.
• The number of infants who declined prophylaxis.
• The severity and location of bleeding.
• A credible publication or public health source.

Conclusion: The Practical Takeaway for Families

Newborns begin life with low vitamin K stores, limited intestinal production, and little vitamin K in human milk. This creates a temporary but important risk of vitamin K deficiency bleeding.

The vitamin K injection is the standard preventive measure in many healthcare systems and the most reliable way to reduce that risk. Refusing it does not guarantee that a baby will bleed, but it removes highly effective protection against a rare and potentially devastating condition.

Parents should discuss the injection, oral alternatives, dosing schedules, and individual risk factors with a qualified clinician before delivery. Any unusual bleeding, severe sleepiness, seizure, repeated vomiting, feeding change, or sudden neurological symptom requires emergency medical evaluation.

For current recommendations, consult a pediatrician, obstetric clinician, hospital newborn team, or national public health authority.

FAQ

What is vitamin K deficiency bleeding in newborns?

Vitamin K deficiency bleeding is bleeding caused by insufficient vitamin K for normal blood clotting. It may occur shortly after birth or later during infancy and can affect internal organs, including the brain.

Why do newborns receive a vitamin K shot?

Newborns have low vitamin K stores, immature intestinal bacteria, and little vitamin K in breast milk. The injection supplies vitamin K during this vulnerable period and reduces the risk of serious bleeding.

Is the vitamin K shot a vaccine?

No. It is a medication that supports blood clotting. It does not train the immune system and is separate from routine childhood vaccines.

Can parents choose oral vitamin K instead?

Some healthcare systems offer oral regimens, but they may require multiple doses and strict adherence. Effectiveness varies by product and protocol. Parents should discuss available options with the baby’s clinician.

What are the warning signs of vitamin K deficiency bleeding?

Warning signs include blood in vomit or stool, black stools, persistent umbilical bleeding, unusual bruising, pallor, extreme sleepiness, seizures, repeated vomiting, feeding changes, or difficulty waking the baby.

What should parents do if they declined the shot and are concerned?

Contact the baby’s healthcare professional promptly to discuss available options. Seek emergency care immediately for bleeding, seizures, severe lethargy, breathing difficulty, collapse, or sudden neurological changes.